| For: | Shakado S, Sakisaka S, Chayama K, Okanoue T, Toyoda J, Izumi N, Matsumoto A, Takehara T, Ido A, Hiasa Y, Yoshioka K, Nomura H, Ueno Y, Seike M, Kumada H. Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development. World J Hepatol 2015; 7(27): 2757-2764 [PMID: 26644819 DOI: 10.4254/wjh.v7.i27.2757] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i27/2757.htm |
| Number | Citing Articles |
| 1 |
Youssef M. Hassan, Hala El-Tantawi, Ibrahim Rabie Ali, Mohamed S. Attia. A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis. Talanta 2027; 311 doi: 10.1016/j.talanta.2026.130103
|
| 2 |
Yue Chang, Baiqing Liu, Haiyan Niu, Zhenguo Wang, Shihai Xia, Hai Li. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma. Medicine 2020; 99(34) doi: 10.1097/MD.0000000000021887
|
| 3 |
Takashi Tanaka, Kazuhide Takata, Takashi Miyayama, Kumiko Shibata, Hiromi Fukuda, Ryo Yamauchi, Atsushi Fukunaga, Keiji Yokoyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43516-w
|
| 4 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8) doi: 10.18632/oncotarget.13929
|